Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jeffery Newell"'
Autor:
Wendy Thanassi, Art Noda, Beatriz Hernandez, Jeffery Newell, Paul Terpeluk, David Marder, Jerome A. Yesavage
Publikováno v:
Pulmonary Medicine, Vol 2012 (2012)
Objective. To find a statistically significant separation point for the QuantiFERON Gold In-Tube (QFT) interferon gamma release assay that could define an optimal “retesting zone” for use in serially tested low-risk populations who have test “r
Externí odkaz:
https://doaj.org/article/44cbf23ba20f4cd98fb8d0b27d1fe098
Autor:
Paul B. Rosenberg, Jeffery Newell, Jerome A. Yesavage, Jacobo Mintzer, Daniel Weintraub, Kelly M. Makino, D.P. Devanand, Constantine G. Lyketsos, David M. Shade, Bruce G. Pollock, Constantine Frangakis, Lon S. Schneider, Lea T. Drye, Matthew E. Peters, Cynthia A. Munro, Anton P. Porsteinsson, Anne K. Leonpacher
Publikováno v:
American Journal of Psychiatry. 173:473-480
Citalopram has been shown to improve agitation in patients with Alzheimer's disease. The authors evaluated whether other neuropsychiatric symptoms improve with citalopram treatment compared with placebo.In this planned secondary analysis of the Cital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33fc384e5839b17ca61a45554cc8ea76
https://doi.org/10.1176/appi.ajp.2016.15020248
https://doi.org/10.1176/appi.ajp.2016.15020248
Autor:
Leah Friedman, Cynthia A. Munro, Jerome A. Yesavage, Art Noda, Steven Z. Chao, Daniel Weintraub, Lea T. Drye, Jacobo Mintzer, Anton P. Porsteinsson, Devangere P. Devanand, Bruce G. Pollock, Michelle Madore, David M. Shade, Helena C. Kraemer, Lon S. Schneider, Paul B. Rosenberg, Jeffery Newell, Joy L. Taylor, Constantine G. Lyketsos
Publikováno v:
Journal of Psychiatric Research. 74:17-21
Background We found a benefit of citalopram for agitation in the Citalopram for Agitation in Alzheimer's Disease study (CitAD), and wondered if this was mediated by a sedative effect. CitAD was a randomized, placebo-controlled, double-blind, parallel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708310846e8d221ce2eb21d21aba88e9
https://doi.org/10.1016/j.jpsychires.2015.12.005
https://doi.org/10.1016/j.jpsychires.2015.12.005
Autor:
Jeffery Newell, Paul B. Rosenberg, Jacobo Mintzer, Christopher Marano, Daniel Weintraub, Constantine G. Lyketsos, Bruce G. Pollock, Constantine Frangakis, Curtis L. Meinert, David M. Shade, Cynthia A. Munro, Gregory H. Pelton, Anton P. Porsteinsson, Lon S. Schneider, Jerome A. Yesavage, Devangere P. Devanand, Zahinoor Ismail, Peter V. Rabins, Lea T. Drye
Publikováno v:
International Psychogeriatrics. 27:2059-2067
Background:Placebo responses raise significant challenges for the design of clinical trials. We report changes in agitation outcomes in the placebo arm of a recent trial of citalopram for agitation in Alzheimer's disease (CitAD).Methods:In the CitAD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09354da46b1db64a9fe7d7bcc9cec047
https://doi.org/10.1017/s1041610215001106
https://doi.org/10.1017/s1041610215001106
Autor:
Paul B. Rosenberg, Jacob Mintzer, Constantine G. Lyketsos, Cynthia A. Munro, Constantine Frangakis, Lon S. Schneider, Bruce G. Pollock, Jeffery Newell, Peter V. Rabins, D P Devanand, David M. Shade, Christopher Marano, Gregory Pelton, Lea T. Drye, Anton P. Porsteinsson, Sonia Pawluczyk, Daniel Weintraub, Lisa Rein, Jerome A. Yesavage, Benoit H. Mulsant
Publikováno v:
The American journal of psychiatry. 173(5)
Pharmacological treatments for agitation and aggression in patients with Alzheimer's disease have shown limited efficacy. The authors assessed the heterogeneity of response to citalopram in the Citalopram for Agitation in Alzheimer Disease (CitAD) st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa8d355f59b7aac79c1722a98f012ac9
https://pubmed.ncbi.nlm.nih.gov/27613071
https://pubmed.ncbi.nlm.nih.gov/27613071
Autor:
Jeffery Newell, Jerome A. Yesavage, Beatriz Hernandez, Wendy Thanassi, Art Noda, Paul Terpeluk, David Marder
Publikováno v:
Pulmonary Medicine
Pulmonary Medicine, Vol 2012 (2012)
Pulmonary Medicine, Vol 2012 (2012)
Objective. To find a statistically significant separation point for the QuantiFERON Gold In-Tube (QFT) interferon gamma release assay that could define an optimal “retesting zone” for use in serially tested low-risk populations who have test “r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8dbabe3bb8e6a4d76abf1f6f119bfe2